Profitelligence Profitelligence · Filing Ledger Open CVS research →

Form 8-K · Current Report · Filed 2024-10-18

CVS Health Appoints New CEO and Provides Preliminary Q3 2024 Guidance

CVS Health announced the appointment of David Joyner as President and Chief Executive Officer, effective October 17, 2024, replacing Karen Lynch who resigned from her position.

Filer
CVS Health Corporation CVS · NYSE
Filed
Accession
0001193125-24-239193
CIK
0000064803
Signal
High impactHealthcare

Details

Roger Farah was appointed Executive Chairman of the Board. The company also provided preliminary guidance for third quarter 2024, projecting GAAP diluted Earnings per Share (EPS) of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10. The preliminary results include charges related to premium deficiency reserves and restructuring costs.

Items reported

Item 2.02

Results of Operations and Financial Condition

General Statement
Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

CEO Resignation New CEO Appointed
Item 7.01

Regulation FD Disclosure

Regulation FD Disclosure
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$63.67

Next session

-8.6%

Since filing

+64.0%

Latest close

$104.43

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from CVS reporting the same item, with the next session's move:

Exhibits (1)

About CVS Health Corporation

CVS Health Corporation is a leading health services company in the United States, offering a comprehensive range of services aimed at improving healthcare accessibility and convenience. Primarily known for its extensive network of pharmacies, CVS Health operates thousands of retail locations nationwide. These outlets provide prescription medications, over-the-counter drugs, health and wellness products, and immunization services. Beyond retail, CVS Health plays a significant role in the healthcare sector through its pharmacy benefit management division, Caremark, which administers prescription drug plans for insurers and employers. Additionally, the company owns Aetna, a major health insurance provider, aligning its services across retail, pharmacy benefits, and insurance solutions to deliver integrated healthcare experiences. With its broad reach and diverse healthcare offerings, CVS Health Corporation holds a critical place in the healthcare market, continuously working to streamline and enhance the delivery of medical services across the country.

Exchange NYSE Industry Healthcare Plans Company website ↗

Never miss another CVS filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts